Anakinra in experimental acute myocardial infarction-does dosage or duration of treatment matter?

Cardiovascular Drugs and Therapy

Volumn 23, Issue 2, 2009, Pages 129-135

  Salloum, Fadi N ^a   Chau, Vinh ^a   Varma, Amit ^a   Hoke, Nicholas N ^a   Toldo, Stefano ^a,b   Biondi Zoccai, Giuseppe G L ^c   Crea, Filippo ^b   Vetrovec, George W ^a   Abbate, Antonio ^a,b,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Anakinra; Apoptosis; Cytokine; Interleukin 1; Myocardial infarction; Remodelling

Indexed keywords

RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE CELL; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLE; TREATMENT DURATION;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MICE; MICE, INBRED ICR; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; TIME FACTORS; VENTRICULAR REMODELING;

EID: 62149110425     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-008-6154-3     Document Type: Article

References (31)

1. A Abbate R Bussani MS Amin GW Vetrovec A Baldi 2006 Acute myocardial infarction and heart failure: role of apoptosis Int J Biochem Cell Biol. 38 1834 1840
2. CA Dinarello BJ Pomerantz 2001 Proinflammatory cytokines in heart disease Blood Purif. 19 314 321
3. Y Seta K Shan B Bozkurt H Oral DL Mann 1996 Basic mechanisms in heart failure: the cytokine hypothesis J Card Fail. 2 243 249
4. A Severino M Campioni S Straino FN Salloum N Schmidt U Herbrand S Frede G Toietta G Di Rocco R Bussani F Silvestri M Piro G Liuzzo LM Biasucci P Mellone F Feroce MC Capogrossi F Baldi J Fandrey M Ehrmann F Crea A Abbate A Baldi 2007 Identification of protein disulfide isomerase (PDI) as a cardiomyocyte survival factor in ischemic cardiomyopathy J Am Coll Cardiol. 50 1029 1037
5. CA Dinarello 1996 Biologic basis for IL-1 in disease Blood. 87 2095 2147
6. H Loppnow K Werdan G Reuter HD Flad 1998 The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system Eur Cytokine Netw. 9 675 680
7. DJ Ing J Zang VJ Dzau KA Webster NH Bishopric 1999 Modulation of cytokine induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x Circ Res. 84 21 33
8. P Libby SJC Warner GB Friedman 1990 Interleukin-1: a mitogen for human vascular smooth muscle cells that induce the release of growth inhibitory prostanoids J Clin Invest. 81 487 498
9. BS Cain DR Meldrum CA Dinarello XZ Meng KS Joo A Banerjee AH Harken 1999 TNF and IL-1 synergistically depress human myocardial function Crit Care Med. 27 1309 1318
10. B Stein P Frank W Schmitz H Scholz M Thoenes 1996 Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase J Mol Cell Cardiol. 28 1631 1639
11. CA Dinarello 1997 Interleukin-1 Cytokine Growth Factor Rev. 8 253 265
12. C Gabay I Kushner 1999 Acute-phase proteins and other systemic responses to inflammation N Engl J Med. 340 448 454
13. G Patti A D'Ambrosio S Mega G Giorgi EM Zardi DM Zardi G Dicuonzo A Dobrina G Di Sciascio 2004 Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction J Am Coll Cardiol. 43 35 38
14. G Patti S Mega V Pasceri A Nusca G Giorgi EM Zardi A D'Ambrosio A Dobrina G Di Sciascio 2005 Interleukin-1 receptor antagonist levels correlate with the extent of myocardial loss in patients with acute myocardial infarction Clin Cardiol. 28 193 196
15. A Abbate FN Salloum E Vecile A Das NN Hoke S Straino GGL Biondi-Zoccai JE Houser IZ Quershi ED Ownby E Gustini LM Biasucci A Severino MC Capogrossi GW Vetrovec F Crea A Baldi RC Kukreja A Dobrina 2008 Anakinra, a recombinant interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction Circulation. 117 2670 2683
16. FN Salloum A Abbate A Das J Houser CA Mudrick IZ Qureshi NN Hoke SK Roy WR Brown S Prabhakar RC Kukreja 2008 Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice Am J Physiol Heart Circ Physiol. 294 H1398 H1406
17. NB Schiller PM Shah M Crawford A DeMaria R Devereux H Feigenbaum H Gutgesell N Reichek D Sahn I Schnittger 1989 Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 358 367
18. LE Teichholz T Kreulen MV Herman R Gorlin 1976 Problems in echocardiographic volume determinations: echocardiographic angiographic correlations in the presence or absence of asynergy Am J Cardiol. 37 7 11
19. A Abbate R Bussani GGL Biondi-Zoccai D Santini A Petrolini F De Giorgio F Vasaturo S Scarpa A Severino G Liuzzo AM Leone F Baldi G Sinagra F Silvestri GW Vetrovec F Crea LM Biasucci A Baldi 2005 Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium Eur Heart J. 26 2039 2045
20. R Kamici JS Karliner F Koudssi CS Long 1998 Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia Circ Res. 82 576 586
21. WP Arend M Malyak CJ Guthridge C Gabay 1998 Interleukin-1 receptor antagonist: role in biology Annu Rev Immunol. 16 27 55
22. U Ikeda M Ikeda S Kano 1994 Neutrophil adherence to rat cardiac myocytes by proinflammatory cytokines J Cardiovasc Pharmacol. 23 647 652
23. K Suzuki B Murtuza RT Smolenski IA Sammut N Suzuki Y Kaneda MH Yacoub 2001 Circulation 104 I308 I313
24. AC Morton ND Arnold J Gunn R Varcoe SE Francis SK Dower DC Crossman 2005 Interleukin-1 receptor antagonist alters the response to vessel injury in a porcine coronary artery model Cardiovasc Res. 68 493 501
25. HC Emsley CJ Smith RF Georgiou A Vail SJ Hopkins NJ Rothwell 2005 Tyrell PJ for the Acute Stroke Investigators. A randomized phase II study of interleukin-1 receptor antagonist in acute stroke patients J Neurol Neurosurg Psychiatry 76 1366 1372
26. DE Furst 2004 Anakinra: review of recombinant human interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis Clin Ther. 26 1960 1975
27. CA Dinarello 2000 The role of interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1 N Engl J Med. 343 732 734
28. Kineret- http://www.kineretrx.com/pi.jsp#topPPI. Last accessed on 20 Jul 2008.
29. R Nixon N Bansback A Brennan 2007 The efficacy of inhibiting tumor necrosis factor alpha and interleukin-1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons Rheumatology (Oxford). 46 1140 1147
30. Regeneron- http://www.regeneron.com. Last accessed 20 Jul 2008.
31. XOMA- http://www.xoma.com/xoma052. Last accessed 20 Jul 2008.